3//SEC Filing
Versant Venture Capital V, L.P. 3
Accession 0001567619-18-003246
CIK 0001656634other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 5:40 PM ET
Size
23.2 KB
Accession
0001567619-18-003246
Insider Transaction Report
Form 3
Holdings
- (indirect: See Footnote)
Series B Convertible Preferred Stock
→ Common Stock (929,020 underlying) - (indirect: See Footnote)
Series A Convertible Preferred Stock
→ Common Stock (2,173,909 underlying)
Holdings
- (indirect: See Footnote)
Series B Convertible Preferred Stock
→ Common Stock (929,020 underlying) - (indirect: See Footnote)
Series A Convertible Preferred Stock
→ Common Stock (2,173,909 underlying)
Versant Venture Capital V, L.P.
10% Owner
Holdings
- (indirect: See Footnote)
Series A Convertible Preferred Stock
→ Common Stock (2,173,909 underlying) - (indirect: See Footnote)
Series B Convertible Preferred Stock
→ Common Stock (929,020 underlying)
Holdings
- (indirect: See Footnote)
Series B Convertible Preferred Stock
→ Common Stock (929,020 underlying) - (indirect: See Footnote)
Series A Convertible Preferred Stock
→ Common Stock (2,173,909 underlying)
Footnotes (4)
- [F1]The shares of the Issuer's Preferred Stock automatically convert into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's initial public offering.
- [F2]The expiration date is not relevant to the conversion of these securities.
- [F3]Consists of (I) 1,907,729 shares held by Versant Venture Capital V, L.P. ("VVC V"), (ii) 145,186 shares held by Versant Venture Capital V (Canada) LP ("VVC CAN"), (iii) 63,610 shares held by Versant Ophthalmic Affiliates Fund I, L.P. ("VOA"), and (iv) 57,384 shares held by Versant Affiliates Fund V, L.P. ("VAF V"). Versant Ventures V, LLC, or VV V, serves as the sole general partner of VOA, VAF V and VVC V and owns no shares directly. Versant Ventures V (Canada) GP-GP, Inc. ("VV V CAN GP"), serves as the sole general partner of Versant Ventures V (Canada), L.P. ("VV V CAN"), which serves as the sole general partner of VVC CAN and owns no shares directly.
- [F4]Consists of (I) 815,302 shares held by Versant Venture Capital V, L.P. ("VVC V"), (ii) 62,048 shares held by Versant Venture Capital V (Canada) LP ("VVC CAN"), (iii) 27,146 shares held by Versant Ophthalmic Affiliates Fund I, L.P. ("VOA"), and (iv) 24,524 shares held by Versant Affiliates Fund V, L.P. ("VAF V"). Versant Ventures V, LLC, or VV V, serves as the sole general partner of VOA, VAF V and VVC V and owns no shares directly. Versant Ventures V (Canada) GP-GP, Inc. ("VV V CAN GP"), serves as the sole general partner of Versant Ventures V (Canada), L.P. ("VV V CAN"), which serves as the sole general partner of VVC CAN and owns no shares directly.
Documents
Issuer
Gritstone Oncology, Inc.
CIK 0001656634
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001589097
Filing Metadata
- Form type
- 3
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 5:40 PM ET
- Size
- 23.2 KB